Pulsed Magnetic Field Improves the Transport of Iron Oxide Nanoparticles through Cell Barriers
Source abstract
Abstract
Understanding how a magnetic field affects the interaction of magnetic nanoparticles (MNPs) with cells is fundamental to any potential downstream applications of MNPs as gene and drug delivery vehicles. Here, we present a quantitative analysis of how a pulsed magnetic field influences the manner in which MNPs interact with and penetrate across a cell monolayer. Relative to a constant magnetic field, the rate of MNP uptake and transport across cell monolayers was enhanced by a pulsed magnetic field. MNP transport across cells was significantly inhibited at low temperature under both constant and pulsed magnetic field conditions, consistent with an active mechanism (i.e., endocytosis) mediating MNP transport. Microscopic observations and biochemical analysis indicated that, in a constant magnetic field, transport of MNPs across the cells was inhibited due to the formation of large (>2 μm) magnetically induced MNP aggregates, which exceeded the size of endocytic vesicles. Thus, a pulsed magnetic field enhances the cellular uptake and transport of MNPs across cell barriers relative to a constant magnetic field by promoting accumulation while minimizing magnetically induced MNP aggregation at the cell surface.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Quantum Dots Synthesis And Properties · Characterization and Applications of Magnetic Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States
Key Laboratory for Green Chemical Process of Ministry of Education, Wuhan Institute of Technology, Wuhan 430073, China
Department of Chemical Engineering, Auburn University, Auburn, Alabama 36849, United States
Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
References (44)
Show source-provided references
1. Ferrari M. · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
2. Medarova Z. · Nat. Med. · 2007 · 13 · 37210.1038/nm1486 ↗
3. Liong M. · ACS Nano · 2008 · 2 · 88910.1021/nn800072t ↗
4. Cheng J. · Pharm. Res. · 2006 · 23 · 55710.1007/s11095-005-9444-5 ↗
5. Dobson J. · Gene Ther. · 2006 · 13 · 28310.1038/sj.gt.3302720 ↗
6. Bulte J. W. M. · J. Magn. Magn. Mater. · 2005 · 289 · 42310.1016/j.jmmm.2004.11.119 ↗
7. Peng X. H. · Int. J. Nanomed. · 2008 · 3 · 311
8. Lu A. H. · Angew. Chem., Int. Ed. · 2007 · 46 · 122210.1002/anie.200602866 ↗
9. Chatterjee J. · J. Magn. Magn. Mater. · 2003 · 257 · 11310.1016/S0304-8853(02)01066-1 ↗
10. Muller K. · Biomaterials · 2007 · 28 · 162910.1016/j.biomaterials.2006.12.003 ↗
11. Chithrani B. D. · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
12. Eberbeck D. · J. Phys. D: Appl. Phys. · 2010 · 43
13. Yuan J. J. · Langmuir · 2006 · 22 · 1098910.1021/la061834j ↗
14. Sonvico F. · Bioconjugate Chem. · 2005 · 16 · 118110.1021/bc050050z ↗
15. Janib S. M. · Adv. Drug Delivery Rev. · 2010 · 62 · 105210.1016/j.addr.2010.08.004 ↗
16. Win K. Y. · Biomaterials · 2005 · 26 · 271310.1016/j.biomaterials.2004.07.050 ↗
17. Yamamoto H. · J. Controlled Release · 2005 · 102 · 37310.1016/j.jconrel.2004.10.010 ↗
18. Min K. A. · Pharmaceutics · 2010 · 2 · 11910.3390/pharmaceutics2020119 ↗
19. Koch A. M. · ChemBioChem · 2005 · 6 · 33710.1002/cbic.200400174 ↗
20. Petri-Fink A. · Eur. J. Pharm. Biopharm. · 2008 · 68 · 12910.1016/j.ejpb.2007.02.024 ↗
21. Kim D. K. · Chem. Mater. · 2003 · 15 · 161710.1021/cm021349j ↗
22. Zhang L. · AAPS J. · 2009 · 11 · 69310.1208/s12248-009-9151-y ↗
23. Thunemann A. F. · Langmuir · 2006 · 22 · 235110.1021/la052990d ↗
24. Dias A. M. G. C. · Biotechnol. Adv. · 2011 · 29 · 14210.1016/j.biotechadv.2010.10.003 ↗
25. Wu W. · Nanoscale Res. Lett. · 2008 · 3 · 39710.1007/s11671-008-9174-9 ↗
26. Cole A. J. · Biomaterials · 2011 · 32 · 629110.1016/j.biomaterials.2011.05.024 ↗
27. Chertok B. · Biomaterials · 2009 · 30 · 678010.1016/j.biomaterials.2009.08.040 ↗
28. Cole A. J. · Trends Biotechnol. · 2011 · 29 · 32310.1016/j.tibtech.2011.03.001 ↗
29. Huang J. · ACS Nano · 2010 · 4 · 715110.1021/nn101643u ↗
30. Socoliuc V. · AIP Conf. Proc. · 2010 · 1311 · 8910.1063/1.3530065 ↗
31. Espurz A. · J. Phys. D: Appl. Phys. · 1989 · 22 · 117410.1088/0022-3727/22/8/024 ↗
32. Chertok B. · J. Controlled Release · 2011 · 155 · 39310.1016/j.jconrel.2011.06.033 ↗
33. Driscoll C. F. · Microvasc. Res. · 1984 · 27 · 35310.1016/0026-2862(84)90065-7 ↗
34. Duran J. D. · J. Pharm. Sci. · 2008 · 97 · 294810.1002/jps.21249 ↗
35. Kim J. S. · J. Vet. Sci. · 2006 · 7 · 32110.4142/jvs.2006.7.4.321 ↗
36. Mondalek F. · J. Nanobiotechnol. · 2006 · 4 · 110.1186/1477-3155-4-4 ↗
37. Dormer K. · Biomaterials · 2005 · 26 · 206110.1016/j.biomaterials.2004.06.040 ↗
38. Arruebo M. · Nano Today · 2007 · 2 · 2210.1016/S1748-0132(07)70084-1 ↗
39. Tromsdorf U. I. · Nano Lett. · 2007 · 7 · 242210.1021/nl071099b ↗
40. Muller R. N. · Magn. Reson. Med. · 1991 · 22 · 17810.1002/mrm.1910220203 ↗
41. Hartwig V. · Int. J. Environ. Res. Public Health · 2009 · 6 · 177810.3390/ijerph6061778 ↗
42. Riches S. F. · Br. J. Radiol. · 2007 · 80 · 48310.1259/bjr/69843752 ↗
43. David A. E. · J. Controlled Release · 2011 · 152 · 6710.1016/j.jconrel.2011.01.033 ↗
44. Gao X. · J. Nanotechnol. Eng. Med. · 2010 · 1 · 031010:1–6